188 related articles for article (PubMed ID: 26028371)
21. Carcinoma ex pleomorphic adenoma of the salivary gland: an immunohistochemical study.
Matsubayashi S; Yoshihara T
Eur Arch Otorhinolaryngol; 2007 Jul; 264(7):789-95. PubMed ID: 17310348
[TBL] [Abstract][Full Text] [Related]
22. Expression of mitotic checkpoint proteins BUB1B and MAD2L1 in salivary duct carcinomas.
Ko YH; Roh JH; Son YI; Chung MK; Jang JY; Byun H; Baek CH; Jeong HS
J Oral Pathol Med; 2010 Apr; 39(4):349-55. PubMed ID: 20040022
[TBL] [Abstract][Full Text] [Related]
23. Increased expression of MUC-1 has close relation with patient survivor in high-grade salivary gland mucoepidermoid carcinoma.
Siyi L; Shengwen L; Min R; Wenjun Y; Lizheng W; Chenping Z
J Oral Pathol Med; 2014 Sep; 43(8):579-84. PubMed ID: 24725122
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological factors are predictors of distant metastasis from major salivary gland carcinomas.
Mariano FV; da Silva SD; Chulan TC; de Almeida OP; Kowalski LP
Int J Oral Maxillofac Surg; 2011 May; 40(5):504-9. PubMed ID: 21251798
[TBL] [Abstract][Full Text] [Related]
25. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group.
Terhaard CH; Lubsen H; Van der Tweel I; Hilgers FJ; Eijkenboom WM; Marres HA; Tjho-Heslinga RE; de Jong JM; Roodenburg JL;
Head Neck; 2004 Aug; 26(8):681-92; discussion 692-3. PubMed ID: 15287035
[TBL] [Abstract][Full Text] [Related]
26. Risk Factors and Survival Associated with Distant Metastasis in Patients with Carcinoma of the Salivary Gland.
Nam SJ; Roh JL; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2016 Dec; 23(13):4376-4383. PubMed ID: 27338749
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas.
Ettl T; Schwarz S; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
Histopathology; 2008 Nov; 53(5):567-77. PubMed ID: 18983466
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological features and treatment outcomes of the rare, salivary duct carcinoma of parotid gland.
Al-Qahtani KH; Tunio MA; Bayoumi Y; Gurusamy VM; Bahamdain FA; Fatani H
J Otolaryngol Head Neck Surg; 2016 May; 45(1):32. PubMed ID: 27184361
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological study of distant metastases of salivary adenoid cystic carcinoma.
Gao M; Hao Y; Huang MX; Ma DQ; Luo HY; Gao Y; Peng X; Yu GY
Int J Oral Maxillofac Surg; 2013 Aug; 42(8):923-8. PubMed ID: 23706387
[TBL] [Abstract][Full Text] [Related]
30. Primary mucosa-associated lymphoid tissue lymphoma of the salivary glands: a multicenter Rare Cancer Network study.
Anacak Y; Miller RC; Constantinou N; Mamusa AM; Epelbaum R; Li Y; Calduch AL; Kowalczyk A; Weber DC; Kadish SP; Bese N; Poortmans P; Kamer S; Ozsahin M
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):315-20. PubMed ID: 21075560
[TBL] [Abstract][Full Text] [Related]
31. Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma.
Abd El-Rehim DM; Pinder SE; Paish CE; Bell JA; Rampaul RS; Blamey RW; Robertson JF; Nicholson RI; Ellis IO
Br J Cancer; 2004 Oct; 91(8):1532-42. PubMed ID: 15480434
[TBL] [Abstract][Full Text] [Related]
32. Risk Factors and Prognosis for Myoepithelial Carcinoma of the Major Salivary Glands.
Su YX; Roberts DB; Hanna EY; El-Naggar A; Saylam G; Frank SJ; Weber RS; Kupferman ME
Ann Surg Oncol; 2015 Oct; 22(11):3701-7. PubMed ID: 25636455
[TBL] [Abstract][Full Text] [Related]
33. [About the prognostic value of Her-2 gene-amplification and cell-proliferation in salivary duct carcinoma of the major salivary glands - a pilot-study].
Jaehne M; Jäkel KT; Röser K; Ussmüller J; Löning T
Laryngorhinootologie; 2001 Sep; 80(9):525-9. PubMed ID: 11555785
[TBL] [Abstract][Full Text] [Related]
34. Salivary duct carcinoma: clinical characteristics and treatment strategies.
Guzzo M; Di Palma S; Grandi C; Molinari R
Head Neck; 1997 Mar; 19(2):126-33. PubMed ID: 9059870
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness.
Sugano S; Mukai K; Tsuda H; Hirohashi S; Furuya S; Shimosato Y; Ebihara S; Takeyama I
Laryngoscope; 1992 Aug; 102(8):923-7. PubMed ID: 1353853
[TBL] [Abstract][Full Text] [Related]
36. Successful treatment of pulmonary metastatic salivary ductal carcinoma with trastuzumab-based therapy.
Prat A; Parera M; Reyes V; Peralta S; Cedrés S; Andreu J; Huguet P; del Campo JM
Head Neck; 2008 May; 30(5):680-3. PubMed ID: 17972317
[TBL] [Abstract][Full Text] [Related]
37. Predictors of outcomes in large cell undifferentiated carcinoma of the major salivary glands.
Schrank TP; Zhan KY; Lentsch EJ
Laryngoscope; 2017 Feb; 127(2):372-376. PubMed ID: 27545825
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological features of mucoepidermoid carcinoma.
Yamazaki K; Ohta H; Shodo R; Matsuyama H; Takahashi S
J Laryngol Otol; 2014 Jan; 128(1):91-5. PubMed ID: 24451647
[TBL] [Abstract][Full Text] [Related]
39. Invasive micropapillary salivary duct carcinoma: a distinct histologic variant with biologic significance.
Nagao T; Gaffey TA; Visscher DW; Kay PA; Minato H; Serizawa H; Lewis JE
Am J Surg Pathol; 2004 Mar; 28(3):319-26. PubMed ID: 15104294
[TBL] [Abstract][Full Text] [Related]
40. Survival in patients with parotid gland carcinoma - Results of a multi-center study.
Honda K; Tanaka S; Shinohara S; Asato R; Tamaki H; Maetani T; Tateya I; Kitamura M; Takebayashi S; Ichimaru K; Kitani Y; Kumabe Y; Kojima T; Ushiro K; Mizuta M; Yamada K; Omori K
Am J Otolaryngol; 2018; 39(1):65-70. PubMed ID: 29089142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
